Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$466M |
| 2 |
Applovin
APP
|
+$349M |
| 3 |
General Dynamics
GD
|
+$272M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$257M |
| 5 |
iShares Global Infrastructure ETF
IGF
|
+$222M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANSS
Ansys
ANSS
|
+$396M |
| 2 |
HES
Hess
HES
|
+$383M |
| 3 |
Apple
AAPL
|
+$362M |
| 4 |
NVIDIA
NVDA
|
+$298M |
| 5 |
Microsoft
MSFT
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.46% |
| 2 | Financials | 12.23% |
| 3 | Consumer Discretionary | 9.45% |
| 4 | Communication Services | 8.8% |
| 5 | Healthcare | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
ABVC BioPharma
ABVC
$26.3M
| $75.5K | ﹤0.01% |
24,821
-12,323
| -33% | -$37.9K |
|
4202
Atlantic American Corp
AAME
$31.4M
| $75.1K | ﹤0.01% |
26,181
-1,771
| -6% | -$4.9K |
|
4203
Zedge
ZDGE
$38.6M
| $73.6K | ﹤0.01% |
25,309
-458
| -2% | -$1.62K |
|
4204
Cibus
CBUS
$147M
| $73.4K | ﹤0.01% |
56,899
-2,071
| -4% | -$3K |
|
4205
Valens Semiconductor
VLN
$170M
| $73.4K | ﹤0.01% |
40,984
-14,348
| -26% | -$32.4K |
|
|
MRCC
4206
DELISTED
Monroe Capital Corp
MRCC
| $73.3K | ﹤0.01% |
+10,442
| New | +$71.7K |
|
4207
Koss Corp
KOSS
$34.8M
| $73.3K | ﹤0.01% |
14,422
-922
| -6% | -$5.22K |
|
|
DAIC
4208
CID HoldCo Inc
DAIC
$799K
| $73K | ﹤0.01% |
+1,150
| New | +$133K |
|
4209
Cue Biopharma
CUE
$113M
| $72.6K | ﹤0.01% |
3,365
-1,054
| -24% | -$24.7K |
|
|
SACH
4210
Sachem Capital Corp
SACH
$39.1M
| $72.4K | ﹤0.01% |
65,199
-62,716
| -49% | -$74.9K |
|
|
PPSI
4211
Pioneer Power Solutions
PPSI
$32.3M
| $72.3K | ﹤0.01% |
16,727
+1,232
| +8% | +$4.42K |
|
4212
KLX Energy Services
KLXE
$45M
| $71.4K | ﹤0.01% |
37,196
+11,292
| +44% | +$21.1K |
|
4213
Spectral AI
MDAI
$49.3M
| $71.4K | ﹤0.01% |
31,305
| – | – |
|
4214
Curis
CRIS
$9.78M
| $71.4K | ﹤0.01% |
2,149
-147
| -6% | -$5.09K |
|
4215
Celularity
CELU
$18.4M
| $70.5K | ﹤0.01% |
34,062
| – | – |
|
4216
Natural Health Trends
NHTC
$14.7M
| $69.5K | ﹤0.01% |
15,535
| – | – |
|
4217
BioAtla
BCAB
$5.46M
| $69.4K | ﹤0.01% |
2,017
| – | – |
|
4218
GeoPark
GPRK
$633M
| $69.3K | ﹤0.01% |
10,872
-3,801
| -26% | -$25.1K |
|
|
NOTE
4219
DELISTED
FiscalNote
NOTE
| $69K | ﹤0.01% |
14,903
-1
| -0% | -$6 |
|
|
ALLR
4220
Allarity Therapeutics
ALLR
$19.3M
| $68.9K | ﹤0.01% |
+43,626
| New | +$54.8K |
|
|
MURA
4221
DELISTED
Mural Oncology
MURA
| $68.9K | ﹤0.01% |
33,295
-3,444
| -9% | -$7.4K |
|
4222
Offerpad Solutions
OPAD
$18.3M
| $68.3K | ﹤0.01% |
1,639
| – | – |
|
4223
OneMedNet
ONMD
$41M
| $67.9K | ﹤0.01% |
62,276
+40,973
| +192% | +$28.9K |
|
4224
Lantern Pharma
LTRN
$33.6M
| $67.8K | ﹤0.01% |
15,589
| – | – |
|
4225
Cosan
CSAN
$3.18B
| $67.6K | ﹤0.01% |
14,692
-1,986
| -12% | -$9.17K |
|
Similar funds
Northern Trust's Q3 2025 Portfolio in Review
As of Q3 2025, Northern Trust held 4,566 positions worth $782B, up 7.5% from $727B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Northern Trust's Q3 2025 filing shows 167 new, 1,770 increased, 2,268 reduced and 144 closed positions. Its largest new stake was Amrize Ltd: 1,020,799 shares worth $49.5M. The largest sale was Ansys, an estimated $396M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- Northern Trust's largest Q3 2025 buy was Amrize Ltd: 1,020,799 shares worth $49.5M.
- Northern Trust added most to Chevron in Q3 2025, an estimated $466M increase.
- Northern Trust's biggest Q3 2025 reduction was Apple, cutting an estimated $362M.
- Northern Trust fully exited Ansys in Q3 2025, selling an estimated $396M.
- Northern Trust's ten largest holdings make up 30% of its $782B portfolio in Q3 2025.
- Northern Trust opened 167 new positions and closed 144 in Q3 2025.
- Northern Trust's portfolio value rose 7.5% quarter-over-quarter to $782B.
Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.